Oncolytics Biotech Inc. (ONCY) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -10.17M | -6.26M | -6.65M | -5.47M | -6.5M | -7.85M | -4.83M | -6.82M | -7.47M | -6.12M | -6.03M | -8.46M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -56.52% | 20.17% | -37.64% | 19.77% | 13% | -28.12% | 19.87% | 19.44% | 4.6% | -3.12% | -41.98% | -22.38% |
| Net Income | -12.89M | -1.51M | -14.4M | -6.17M | -6.69M | -8.02M | -9.54M | -7.26M | -6.89M | -3.95M | -9.93M | -7.44M |
| Depreciation & Amortization | 22.31K | 0 | 93K | 94K | 97K | 98K | 105K | 98K | 123K | 107K | 103K | 96K |
| Stock-Based Compensation | 3.21M | 0 | 4.12M | 523K | 1.21M | 1.2M | 445K | 506K | 576K | 759K | 750K | 242K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -707K | 444K |
| Other Non-Cash Items | 1.14M | -5.29M | 950K | 293K | -262K | -163K | -155K | -382K | -1.24M | -4.57M | 74K | 75K |
| Working Capital Changes | -1.65M | 537.73K | 2.59M | -216K | -854K | -960K | 4.32M | 215K | -33K | 1.53M | 3.67M | -1.88M |
| Change in Receivables | -541.09K | -7.15K | 18K | 17K | -21K | 0 | 1.47K | -1.47M | -87K | 615K | -71K | 171K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -8.37K | -936 | -7K | 0 | 0 | -6K | -32K | -155K | -46K | -3K | 6.77M | 6.79M |
| Capital Expenditures | -8.37K | -936 | -7K | 0 | 0 | -6K | -32K | -155K | -46K | -3K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.77K | 6.79K |
| Cash from Financing | 10.62M | 2.61M | 4.14M | 5.37M | 5.89M | 3.34M | -173K | 1.98M | 1.5M | 1.74M | 21.29M | 3.69M |
| Debt Issued (Net) | 0 | 0 | -101K | -102K | -103K | -100K | -80K | -65K | -103K | -104K | -102K | -100K |
| Equity Issued (Net) | 10.62M | 5.02M | 4.24M | 5.47M | 5.99M | 3.44M | -158K | 2.04M | 1.6M | 1.47M | 21.33M | 3.45M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -2.41M | 0 | 0 | 0 | 0 | 65K | 0 | 0 | 375K | 63K | 343K |
| Net Change in Cash | 405.82K | -3.67M | -2.27M | -677K | -639K | -3.66M | -5.25M | -4.75M | -5.31M | -5.07M | 22.46M | 1.65M |
| Free Cash Flow | -10.17M | -6.26M | -6.66M | -5.47M | -6.5M | -7.85M | -4.86M | -6.97M | -7.51M | -6.13M | -6.03M | -8.46M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -56.52% | 20.22% | -36.88% | 21.55% | 13.53% | -28.15% | 19.34% | 17.61% | 4.07% | -3.19% | -41.69% | -22.17% |
| FCF per Share | -0.09 | -0.07 | -0.07 | -0.06 | -0.08 | -0.10 | -0.06 | -0.09 | -0.10 | -0.08 | -0.09 | -0.13 |
| FCF Conversion (FCF/Net Income) | 0.79x | 4.16x | 0.46x | 0.89x | 0.97x | 0.98x | 0.51x | 1.29x | 1.08x | 1.55x | 0.81x | 1.53x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27K | 7K | 0 |